Charles Oh, M.D., joined Centrexion Therapeutics as Senior Vice President, Clinical and Medical, in September 2025. Charles brings over 20 years of experience in clinical development and medical affairs in the pharmaceutical/biotech industry. Prior to joining Centrexion, he served as the Chief Medical Officer of Corium, LLC. Prior to Corium, he held senior leadership roles at Acorda Therapeutics, Purdue Pharma, and Johnson & Johnson. Charles led development teams in achieving approvals of multiple drugs and devices in both the United States and the European Union with therapeutic indications in pain, cardiology, and neurology. He graduated with a B.S. from the University of Miami, an M.D. from the Washington University School of Medicine, and an M.B.A. from the University of North Carolina at Chapel Hill. He trained in internal medicine at Thomas Jefferson University and in Cardiology at the University of Florida Health Science Center.